The premier healthcare incubator collaborates with industry-leading
AI company to help healthcare organizations find the right collaborators.
CHICAGO–(BUSINESS WIRE)–MATTER, the premier healthcare incubator and innovation hub, and rMark
Bio, an industry-leading life sciences AI company and a MATTER member
since 2016, today announced the launch of Origin™. Exclusively available
to MATTER’s startup members and partner organizations, Origin combines
the power of machine learning with MATTER’s expertise in vetting,
coaching and convening to accelerate innovation via collaboration.
“MATTER works with entrepreneurs who are developing solutions that can
meaningfully improve health and healthcare, and we work with established
organizations that need innovative ideas,” said MATTER CEO Steven
Collens. “We help the right people find each other at the right time, so
they can collaborate on developing and implementing solutions that
improve health and care.”
Built on rMark Bio’s machine learning platform, Fabric™, Origin is an
intelligent matchmaking engine that connects pharmaceutical companies,
payers and health systems with the right startup collaborators. Every
match recommended by Origin is validated by MATTER before facilitating
the right kind of introduction so that every collaboration is set up for
“Through MATTER, we had the opportunity to make the right connection at
exactly the right time in rMark Bio’s development,” said Jason Smith,
co-founder and CEO of rMark Bio. “Origin is designed to scale
opportunities like ours. We’re using best-in-class modeling to help
MATTER cut through the noise and optimize opportunities for startups and
large organizations alike.”
Origin is now available. Learn more here.
At MATTER, we believe collaboration is the best way to improve
healthcare. The MATTER collaborative includes 200 cutting-edge startups
from around the world, working together with hospitals and health
systems, universities and industry-leading companies to build the future
of healthcare. Together we are accelerating innovation, advancing care
and improving lives. For more information, visit matter.health
and follow @MATTERhealth.
About rMark Bio
rMark Bio Inc. was created to deliver AI solutions that accelerate
innovation, collaboration and scientific discoveries for life sciences
companies. Founded in 2015 by CEO Jason M. Smith and Chief Scientist Lev
Becker, PhD, rMark Bio is based in Chicago and Seattle. rMark Bio
provides services to many of the Top 20 pharmaceutical companies
globally and has partnered with industry-leading technology and
healthcare organizations, including Microsoft, nVidia, Google and MATTER.